Therapy guide · medical education

Nail fungus: the full therapy pathway

Half the thick, yellow, crumbly nails brought to clinics aren't fungal at all — and the pharmacy shelf can't cure the ones that are. Here is the test that should come before any therapy, the honest ceiling of what you can buy, and the prescription tier where cure rates actually live.

Before anything else

Not everyone should start at the bottom of this pathway. These presentations are reasons to see a clinician without waiting out an over-the-counter trial first.

  • A new dark streak, patch or band under a nail See a dermatologist soon

    Subungual melanoma is rare and treatable when caught early, and its classic disguise is 'a bruise that never grows out'. A dark change without a clear injury — especially one that widens or bleeds pigment onto the skin beside the nail — gets a clinician's eyes promptly and no home treatment meanwhile.

  • Nail trouble of any kind with diabetes, neuropathy or poor circulation See a dermatologist soon

    Thick, sharp-edged fungal nails injure the skin around them, and in a foot that can't feel or heal well, that's the opening chapter of ulcers and worse. This combination moves nail care from the bathroom to podiatry as a standing arrangement, and lowers the bar for treating the infection itself.

  • A hot, swollen, intensely painful nail fold — or spreading redness up the toe or finger Seek care quickly

    Acute paronychia and cellulitis are bacterial problems on a clock, not fungal ones on a calendar. Antifungal anything is the wrong aisle; this needs assessment within days, same-day if redness is advancing.

  • Nail changes plus joint pain, or pitting across several nails Worth a clinician visit

    Nail psoriasis is associated with psoriatic arthritis — which damages joints irreversibly and rewards early treatment. Pitted, lifting nails alongside stiff or swollen joints is a rheumatology-relevant pattern, not a pharmacy one.

  • A 'fungal nail' that has already ignored a completed oral course Worth a clinician visit

    Genuine treatment failure happens, but so do wrong diagnoses, reinfection from an untreated foot, and resistant organisms — and each has a different fix. A second course without a re-test and a rethink is the least informative money on this page.

Which part of this pathway is yours?

What this looks like

Clinicians grade this by how much of which nails is involved, and from which direction the fungus entered — because that geometry, more than anything else, decides whether topicals have a chance or the tablet tier is the honest starting point.

Early, edge-first involvement

The common opening: infection creeping under the far edge of the nail, affecting a modest fraction of one or two nails.

What it looks like: A yellow-white streak or wedge starting at the free edge and working back, with early thickening and debris under the tip. This is the presentation where prescription lacquers have their best odds — the drug's journey to the fungus is shortest.

Established infection

Most of a nail plate involved, or several nails at once — the majority presentation by the time people seek help.

What it looks like: Thickened, opaque, yellow-to-brown plates that crumble when trimmed, debris packed beneath, sometimes a detaching edge. At this stage topicals alone are the long-odds bet, and oral treatment becomes the evidence-backed default for anyone who can take it.

Severe or destructive disease

Nails largely destroyed, lifted, or infected down to the base — including the total-dystrophy end-stage.

What it looks like: Grossly thickened, distorted, partly detached plates; walking discomfort from nail bulk; shoes that suddenly matter. Treatment here is combination work — orals plus aggressive debridement, occasionally removal of the worst plates — with managed expectations about how much normal nail can be recovered.

The look-alikes

Not a stage — a standing reminder that a large share of nails carrying this page's appearance carry a different diagnosis.

What it looks like: Pitting and salmon patches (psoriasis), symmetrical ridging and thickening on both big toes (footwear trauma), uniform age-related changes across all nails, or a nail fold that's red and swollen rather than a plate that's crumbly (usually yeast or bacteria — different treatment entirely). The confirmation test exists because these are indistinguishable often enough to humble everyone.

Three things that change the plan regardless of severity

Diabetes or poor circulation

This changes the stakes more than the treatment: thickened fungal nails can wound the neighbouring skin, and in feet with impaired sensation or blood supply, small wounds are how serious trouble starts. Fungal nails in a diabetic foot are a podiatry-and-clinician matter from day one — treatment thresholds drop, and self-managed sharp instruments around those toes are off the menu.

Athlete's foot, past or present

The foot's skin is usually where the nail infection came from and where reinfection will come from next. Peeling toe-webs, scaling soles or recurrent itch mean the reservoir is active — and treating the nail while ignoring it is the classic recipe for a cure that doesn't last. Conveniently, this is the one part of the ecosystem the pharmacy genuinely handles well.

Other medicines and liver history

The oral tier interacts with the rest of a prescription list — itraconazole in particular has a long interactions ledger — and terbinafine decisions take liver history into account. None of this rules the tablets out for most people; it means the medication review isn't a formality, and it's why 'just give me the pills' skips a step that exists for a reason.

Age and nail growth rate

Nails slow with age, and success is delivered by growth — so the same cure takes visibly longer at seventy than at thirty, and the cost-benefit of aggressive treatment shifts. For some, expert trimming and thinning that keeps nails comfortable and shoes wearable is a legitimate endpoint in itself, chosen rather than defaulted into.

Pregnant or nursing

The oral antifungals are deferred in pregnancy, and starting even topical courses usually waits — straightforwardly because this condition moves so slowly that delay costs almost nothing. A nail infection is one of medicine's most postponable problems, and postponement here is the plan, not a compromise.

What else it could be

  • Nail psoriasis — Pitting like a thimble's surface, oil-drop discolouration, and lifting — often with psoriasis somewhere else, sometimes without. Antifungals do nothing for it, and it coexists with true fungal infection often enough that testing pays twice.
  • Trauma and footwear damage — Runners' and hikers' big toenails, thickened symmetrically after years of shoe contact — remodelled, not infected. The history of the sport or the shoes usually tells the story a culture confirms.
  • Ageing nails — Uniform thickening, ridging and yellowing across all nails, arriving gradually and symmetrically. A single dramatically different nail is suspicious; ten identically weathered ones are usually just mileage.
  • Paronychia — nail-fold infection — The fold beside or behind the nail red, swollen, tender — wet-work hands especially. Different organisms, different treatment; the plate itself is a bystander.
  • Subungual melanoma — The one that must never be missed: a new dark streak or patch under a nail, especially one that widens, darkens, or spreads pigment onto the surrounding skin. Rare — and the reason any dark nail change goes to a clinician before anything else on this page.

One number reorganises this whole condition: studies of nails referred as 'fungal' find no fungus in somewhere between a third and half. That is why the pathway's first move is a test rather than a purchase — a clipping is painless, cheap, and converts every subsequent month of treatment from a bet into a plan.

Why it happens

Onychomycosis is a fungal colony living where treatment struggles to follow: in and under the nail plate, feeding on keratin. Usually the invaders are dermatophytes — the same organisms behind athlete's foot, which is where most toenail infections actually start; the foot's skin is the beachhead, the nail the fortress. Once established, the fungus thickens the plate, turns it yellow-brown, crumbles its edge, and slowly lifts it from the bed. Two physical facts explain everything frustrating about treatment. The nail plate is a dense keratin shield that topical drugs cross poorly — which is why creams that clear skin infections in weeks do little for the nail above one. And nails replace themselves at geological speed: a toenail takes twelve to eighteen months to grow out fully, so even a perfectly working treatment shows results at the base first while the damaged tip waits its turn to be cut away. Cure, when it happens, arrives by millimetres.

Anyone squinting at a thick, discoloured toenail wondering whether it's fungus, injury or age; anyone who has painted on pharmacy lacquers for a year to no effect and wants to know if that was ever likely to work; anyone weighing tablets against their reputation; and anyone for whom this is quietly a sandals-and-swimming-pool confidence issue — which is most people who search for it, and a legitimate reason to treat.

Orientation, not diagnosis. This page maps confirmed fungal nail infection. The word 'confirmed' is doing real work: psoriasis, repeated micro-trauma from footwear and sport, ageing changes, yeast infections of the nail fold, and rarer conditions all produce nails that look the part. The single highest-value step on this page costs the least — a nail clipping sent for microscopy and culture before anything is bought or prescribed. Clinicians who insist on it aren't being slow; they're declining to aim months of treatment at a guess.

Everything here is available without a prescription

The over-the-counter pathway

Here is the plainest ceiling on this site, stated without cushioning: no over-the-counter product is approved to cure fungal infection of the nail plate, and the pharmacy aisle labelled 'fungal nail' is mostly selling adjacency to that claim. The monograph antifungals in those kits — tolnaftate, undecylenic acid — are skin drugs; on the plate itself, the keratin shield defeats them. What the shelf genuinely offers is everything around the cure: terbinafine and azole creams that clear the athlete's-foot reservoir feeding the nail (and preventing its reinfection — real, evidence-backed value); urea preparations that soften and thin diseased plate, making nails comfortable and prescription topicals more effective; files, clippers and hygiene that manage bulk; and prevention for the nine other nails. That supporting role matters — it's just not the role the packaging implies. The treatments with actual nail-cure rates sit at the prescription tier, and arriving there early, test in hand, beats a year of hopeful painting.

Appropriate for: The reservoir and the perimeter: active athlete's foot, post-cure prevention, softening and thinning thick nails for comfort, and supporting a prescription topical course. Not appropriate as the sole plan for curing an established nail infection — that expectation is the aisle's most reliable disappointment.

This pathway is candid about being a supporting act: the aisle cannot cure an infected nail plate, and pretending otherwise costs people years. What it can do is everything around the cure — confirm the problem is worth treating, close the reservoir that feeds it, manage the bulk, and defend the result. Done in order, these steps either resolve the situation honestly or deliver you to a prescriber with the case pre-built.

The rule the whole condition obeys: test before treating

Between a third and half of fungal-looking nails contain no fungus — they're psoriasis, old trauma, or age doing their quieter work. Every antifungal, from the pharmacy pen to the prescription tablet, does precisely nothing for those. One painless clipping sent to a lab settles the question for less than the cost of most 'nail renewal' kits, which is why the smartest purchase on this pathway isn't a product at all.

Four rules before the first purchase

  1. The clipping test outranks every product — arrange it first, treat second.
  2. The aisle's real targets are the foot's skin and the nail's bulk; nothing on it cures the plate.
  3. Progress lives at the nail base and moves a millimetre a month — photograph it or lose it.
  4. Dark streaks, hot swollen nail folds, and diabetic feet exit this pathway to a clinician immediately.
  1. This week — before buying anything

    Get the nail tested

    Turn a guess into a diagnosis.

    What this step involves

    Morning

    1. Book the clipping A GP visit (in some places a podiatrist or pharmacist can route it) — clippings and under-nail debris to the lab for microscopy and culture. Painless, cheap, decisive.

    Evening

    1. Keep the nail treatment-naive meanwhile Antifungals already applied can suppress the culture into a false negative — one of the few situations where doing nothing is the rigorous choice.

    Why this step: The guideline literature is blunt: confirmation before systemic treatment is standard practice, and the false-positive rate of eyeballing nails is why. A negative result redirects you to the actual problem; a positive one names the organism, which shapes the drug choice tiers above.

    Ready for the next step?

    Is the test arranged (or the result already in hand)?

    Yes — confirmed fungal: Proceed with the steps below as groundwork, and take the branch that matches how much nail is involved. Go to step 1 ↓

    It came back negative: Genuinely good news: stop shopping this aisle. Thickened non-fungal nails belong with a podiatrist or GP for their real cause — and everything antifungal would have been wasted.

  2. Weeks 1–4, alongside everything else

    Clear the foot that feeds the nail

    Close the source so any cure can hold.

    What this step involves

    Morning

    1. Treat the skin, thoroughly Terbinafine or azole cream over toe-webs and soles — the whole terrain, not the one peeling patch — for the full course on the packet.

    Evening

    1. Change the microclimate Dry between the toes after every wash, daily sock changes, shoe rotation so each pair dries fully. The fungus's business model is trapped moisture; this is the rent increase.

    Why this step: Most nail infections are seeded and re-seeded from the foot's skin, and reservoir control is standing guideline advice precisely because cures that ignore it get reinfected. It's also the one battlefield where the shelf's antifungals genuinely win.

    Ready for the next step?

    Is the foot's skin clear and the drying-and-rotation routine actually running?

    Yes, both: The ecosystem is on your side — whatever tier treats the nail now does so with the source closed. Go to step 2 ↓

    The skin keeps flaring: Persist with the full course and the habits; skin that still flares after a genuine month is worth adding to the clinician conversation.

  3. Ongoing

    Soften, thin, and manage the bulk

    Comfort now, better drug penetration later.

    What this step involves

    Morning

    1. Urea on the diseased plate High-strength urea daily (often under a plaster) softens thick keratin over days to a couple of weeks — repeat in cycles as needed.

    Evening

    1. File and trim what softened Straight across, gently, with tools dedicated to the affected nails and disinfected after. The goal is thin and comfortable, not excavated.

    Why this step: Debridement is standard adjunct practice: it relieves shoe pressure immediately, removes the debris mass that shelters the fungus, and thins the wall every topical above this rung must cross. Diabetic and poorly-perfused feet outsource this entire step to podiatry — that's a safety rule, not a suggestion.

    Ready for the next step?

    Are the nails thinned to comfortable, with the filing routine sustainable?

    Yes: Groundwork complete — the treatment decision above the shelf is now well-prepared. Go to step 3 ↓

    Too thick or painful to manage at home: That's a podiatry referral, not a failure — professional debridement exists precisely for nails past the bathroom tier.

  4. With the test result and groundwork in hand

    Make the therapy decision deliberately

    Choose cure, containment, or referral — on purpose.

    What this step involves

    Morning

    1. Match the branch to the nail Early edge-only involvement → the prescription-lacquer conversation. Established or multiple nails → the oral-course conversation. Either way, the appointment is short because steps zero through two already happened.

    Evening

    1. Or choose containment, openly If treatment isn't right for you — age, medications, indifference to cosmetics — the maintenance matrix above formalises the alternative: thin, trimmed, foot kept clear, spread contained.

    Why this step: The honest function of this pathway is routing: the cures live above the counter, and the aisle's job was to confirm, prepare and protect. Arriving at the prescriber with a positive culture, a treated foot and thinned nails is arriving as the easiest patient of their week.

    Ready for the next step?

    Has a deliberate decision been made — treat at the prescription tier, or contain at this one?

    Yes, decided: Then this pathway did its whole job. The branch ladders above carry the treatment story from here. Go to the checkpoint ↓

    Still drifting: Drifting is the one strategy with no upside — the infection compounds slowly while options stay identical. Book the conversation; deciding is cheap.

The checkpoint — is it working?

The checkpoint here is a decision, not a product verdict

As soon as the test result, the reservoir work and the bulk management are all in hand — typically a month from starting.

How to judge it: By completeness, not by the nail's appearance: diagnosis confirmed or refuted, foot cleared, plate thinned, and a deliberate choice made about the tier above. The nail itself will not have visibly changed — it was never going to this early, whatever was applied to it.

Where did the groundwork land you?

The pathway's main exit, taken with the case pre-built.

Take the branch that fits the involvement: early-and-limited toward the modern lacquers, established toward the oral course whose evidence leads the field. Your culture result, cleared foot and thinned nails are precisely the preparation those tiers assume — the appointment starts at the decision instead of the beginning.

A legitimate, stable strategy when chosen with open eyes.

The maintenance matrix is now the plan: urea and trimming for comfort, the foot kept permanently clear, footwear that accommodates, and podiatry standing by for what home tools shouldn't attempt. Revisit the decision if pain arrives, spread accelerates, or the medication landscape that ruled out tablets changes.

The pathway's best save: months of pointless antifungals cancelled by one clipping.

Thickened non-fungal nails have real causes with real answers — psoriasis (which has its own page here), footwear trauma, age — and the right professional is a GP, podiatrist or dermatologist depending on the picture. Everything antifungal comes off the shopping list; the drying-and-trimming habits can stay, since they cost nothing and offend no diagnosis.

See the prescription pathway →

The imperfect-world route — proceed, but with eyes open.

Where testing truly isn't accessible, clinicians do sometimes treat on clinical appearance — that's their judgement call to make, not the aisle's. What remains yours: the reservoir and bulk work above lose nothing either way, and an unconfirmed nail deserves extra skepticism at every expensive fork — particularly the cash-pay device tier, where an unverified diagnosis meets unverified treatment.

These leave the pathway immediately, at any step

A new dark streak or patch under any nail (clinician promptly — it must be distinguished from melanoma before anything else happens), a hot swollen painful nail fold or redness spreading up the digit (bacterial, urgent-adjacent), and any nail trouble in a diabetic or poorly-perfused foot (podiatry-and-clinician territory from the start).

This condition rewards the long watch: monthly base-of-nail photos during any treatment, an athlete's-foot reflex measured in days not months, and shoes that get to dry. Recurrence is a lifelong possibility rather than a prediction — the prevention habits are what keep it in the 'possibility' column.

Where the over-the-counter pathway ends

It ends where it honestly began: at the fact that nail-plate cure is prescription territory. What the aisle handed over is everything else — a confirmed diagnosis, a closed reservoir, a thinned plate, and a decision made deliberately. The tiers above run on exactly those inputs: lacquers engineered for early disease, an oral course with the field's best cure rates at generic prices, and specialist combinations for the stubborn cases. Cross with the culture result in hand; it's the document every subsequent choice quotes.

See the prescription pathway →

Nail fungus: the full therapy pathway · dermapproved.com/treatments/nail-fungus/ · not a diagnosis — confirm anything you act on with a clinician

What to expect

Recalibrate two instincts and this condition becomes manageable. The first is the clock: nothing here works on skincare time. A successful course shows nothing for months, then a sliver of clear nail at the base, then a slow tide — full verdicts at nine to eighteen months, delivered by growth and clippers rather than by transformation. The damaged part of the nail never heals; it gets replaced, millimetre by millimetre, which is why the base is the only place worth watching. The second is the win condition: cure rates even for the best treatment leave a meaningful minority needing a second act, recurrence is a lifelong possibility that prevention habits keep pruning, and for some nails and some seasons of life, contained-and-comfortable is the smarter target than cured. Within those recalibrations, genuine optimism: confirmed infections treated with the evidence-backed tiers mostly improve, the strongest option costs pennies a day, and the habits that protect a cure cost almost nothing at all.

  • Test before treating — the founding rule of the whole page, worth repeating exactly once more
  • Watch the base, not the tip: clear growth at the cuticle is success; the wrecked edge was always leaving by clipper
  • Finish oral courses on schedule and judge them months later — the drug outlasts its own prescription inside the plate
  • A lacquer course is a nine-month daily contract; sign it honestly or choose a different tier
  • The foot reservoir and the shoe archive undo more cures than pharmacology fails — the boring habits are load-bearing

The site keeps pace with the long haul: the nail-care shelf arrives with the catalog's expansion and will grade the urea, foot-antifungal and prevention products this page keeps pointing at, and the photo tracker is built for exactly the month-over-month base-watching this condition demands. When the shelf lands, the cards above start showing browsable picks in place.

What would bring you back sooner

Whatever step you are on, these do not wait for the end of a trial period. They are the same presentations listed at the top of this page — repeated here because that is where they matter, rather than where they were easiest to put.

  • A new dark streak, patch or band under a nail See a dermatologist soon
  • Nail trouble of any kind with diabetes, neuropathy or poor circulation See a dermatologist soon
  • A hot, swollen, intensely painful nail fold — or spreading redness up the toe or finger Seek care quickly
  • Nail changes plus joint pain, or pitting across several nails Worth a clinician visit
  • A 'fungal nail' that has already ignored a completed oral course Worth a clinician visit

Why each of these does not wait →

Everything above is available without a prescription Everything below needs one
Prescription only — from here on, this is a clinician's decision

The prescription pathway

Why this tier exists. What the aisle cannot do, stated once more without softening: cure an infected nail plate. It also cannot tell you whether the nail is infected at all — and a third to half aren't — which is why the test outranks every purchase. Expect the shelf to manage comfort, reservoirs and recurrence; expect cure, where it's available, to come from the tier above.

This map is unusual: its first checkpoint is a diagnosis, not a product. Everything downstream — the shelf's limited role, the lacquers, the tablets — depends on whether the nail is actually infected, and a large share aren't. The routes split on how much nail is involved; all of them run on the slowest clock this site covers, because success is measured in regown nail.

Nail fungus: the full therapy pathway — the prescription pathway Escalation levels (Rx topical, Rx oral, Procedure) down the side, presentations across the top. Early and limited — a wedge in one or two nails runs Over-the-counter then Rx topical then Rx oral. Established — most of a plate, or several nails runs Over-the-counter then Rx oral then Procedure. Arrows between steps mark the fair-trial checkpoint at which care escalates. Where the over-the-counter pathway ends Rx topical Rx oral Procedure Early and limited — a wedge in one or two nails 2–4 weeks, no real change A plate-penetrating topical, for a full growth… Prescription nail topicals if it doesn’t work The oral course, if topicals don't close it Oral terbinafine · Oral azoles and the second line specialist judgment beyond here Established — most of a plate, or several nails 2–4 weeks, no real change Oral terbinafine — the evidence's first choice Oral terbinafine · Oral azoles and the second line if it doesn’t work Combination work for the stubborn and the severe Professional debridement and nail removal · Prescription… specialist judgment beyond here After control Managing, preventing, and staying cured Reinfection is the sequel nobody budgets for — prevention is cheaper than every tier above
Routes across the top, escalation level down the side. The dashed first connector is the confirmation test — the one step that should precede every other, because treating an uninfected nail with antifungals wastes months by design. Above it, escalation follows nail involvement, not impatience.

The same pathway in full below — each step names what it involves, why it sits where it does, and what tells you it's time to move up. Tap any therapy to jump to its detail.

Early and limited — a wedge in one or two nails

Infection confirmed, caught early: an edge-first wedge or streak in one or two nails, base untouched. The one presentation where topical cure odds are genuinely respectable — and where acting now, rather than watching it spread for two more years, is the whole game.

You reach this column when: Confirmation is positive — which on this branch simply means proceed to the lacquer rung with the groundwork done.

  1. Prescription topical

    A plate-penetrating topical, for a full growth cycle

    Why this step sits here: Early, limited, distal disease is exactly the population where the modern topicals earned their approvals — the diffusion path is short and the base is clean. The commitment is the fine print: daily or weekly application for nine to twelve months, judged by clear nail advancing from the base, with the foot kept clear throughout.

    When to move up

    A fair trial
    Six months of consistent application before the first serious verdict — earlier judgement is judging the old nail, not the treatment.
    Improvement looks like
    A widening band of normal nail at the base while the damaged zone marches toward the clippers. Photographs monthly; growth is invisible in real time.
    Move up if
    No clear base-growth by six months, involvement spreading toward the base or new nails, or the daily ritual has honestly collapsed — adherence failure is information too.

    → The next step up this pathway.

  2. Prescription oral

    The oral course, if topicals don't close it

    Why this step sits here: A limited infection that shrugs off a real topical course gets the same answer as established disease: systemic treatment, with its better cure rates and finite course. Nothing was lost by trying topicals first here — that's what this branch is for — but the second-line conversation shouldn't drag past the evidence.

    Keep the original culture result on file for this appointment — if a re-test is ordered, knowing whether the organism changed is precisely the kind of detail that separates a smart second course from a hopeful one.

Established — most of a plate, or several nails

Confirmed infection occupying serious territory: a mostly-involved plate, multiple nails, or thickening that's past what lacquers reliably cross. The evidence is unusually clear about this branch: the tablets are the honest starting proposal, not the last resort.

You reach this column when: Confirmation is positive and you're cleared for systemic treatment — the default forward path on this branch.

  1. Prescription oral

    Oral terbinafine — the evidence's first choice

    Why this step sits here: High-quality evidence, guideline consensus, generic price: a twelve-week terbinafine course is the strongest move this condition allows, with azoles as the tailored alternative when organism or interactions argue for one. The course is finite; the judging period isn't — the drug keeps working in the plate while a year of nail grows out.

    When to move up

    A fair trial
    The full course, then patience: toenails render verdicts at nine to twelve months from the first tablet, at the growth line, ideally in photographs.
    Improvement looks like
    Clear nail claiming territory from the base month by month. The damaged distal zone never improves — it gets evicted by growth and clippers, which is the win condition.
    Move up if
    No clean base-growth by month six, or clear regrowth that re-infects — each triggering a re-test and a rethink rather than a reflex second course.

    → The next step up this pathway.

  2. In-office procedure

    Combination work for the stubborn and the severe

    Why this step sits here: Past a failed or unsuitable oral course, the game becomes combinations: professional debridement plus long topicals, removal of the worst plates with antifungal cover, organism-matched second courses — and, for those who choose it with open eyes, the device tier at its honest evidence size. This is specialist chess, played per-nail.

    At this rung, redefine winning before spending: for some nails and some lives, 'comfortable, trimmed, and contained' beats another year pursuing 'cured' — and choosing that on purpose, with a podiatrist's help, is a legitimate success state rather than a surrender.

Managing, preventing, and staying cured

The long-game branch: while a course runs, after it succeeds, or when treatment isn't the right call at all. Fungus is patient; this branch is about being more patient back.

Mid-course — tablets swallowed or lacquer drying

The course treats the nail; you treat the ecosystem. Feet washed and thoroughly dried (between the toes is the whole game), socks changed daily, shoes rotated to dry out, foot antifungal at the first itch — and monthly photos of the nail base, which is where the verdict will eventually appear.

Cured — and intending to stay that way

Recurrence stalks this condition, and the counter-moves are all shelf-level: the athlete's-foot reflex (treat any peeling web the week it appears), sandals in communal showers and pool decks, no shared clippers, old shoes either treated with antifungal powder or retired — they're the fungus's archive. A cured nail plus an old habit is a countdown.

Treatment isn't the plan — comfort is

For some — advanced age, slow-growing nails, medication lists that veto orals, or simple indifference to cosmetics — containment is the rational choice: nails kept thin and trimmed, feet kept fungus-free so it spreads no further, shoes that accommodate. Chosen deliberately, this is management, not neglect; the door to treatment stays open if the calculus changes.

High-risk feet — diabetes, neuropathy, poor circulation

This row overrides the others: routine professional foot care as a standing arrangement, home blades retired, any skin break or colour change reported early, and a lower threshold for treating the infection itself — because here a thick nail isn't cosmetic, it's a pressure instrument next to skin that can't afford wounds.

Nail fungus: the full therapy pathway · dermapproved.com/treatments/nail-fungus/ · not a diagnosis — confirm anything you act on with a clinician

Getting seen

How an appointment actually happens, what to take to it, and how to keep your skin liveable while a prescription or procedure does its work.

What seeing a dermatologist actually looks like

The entry point is deliberately humble: a GP or family doctor can take the clipping, send it for microscopy and culture, screen your medication list, and prescribe the entire oral tier — this is one of the pathways where primary care genuinely covers most of the map. Podiatry is the parallel track for debridement, thick-nail comfort and high-risk feet, and in several countries pharmacists can supply lacquers for confirmed limited disease. Dermatology referral fits the puzzles: diagnostic uncertainty after testing, failed courses, non-dermatophyte organisms, or nails that suggest psoriasis and its joint questions.

What to bring

  • The nail untouched by treatment for a couple of weeks if possible — antifungals suppress the very culture that would confirm them
  • Your full medication list including supplements; the oral-tier decision is made against it
  • Any liver history, alcohol picture worth mentioning, and for itraconazole questions, any cardiac history
  • The timeline: which nails, since when, spreading or stable, and any old injury to the nail in question
  • Photos across time if you have them — nails change too slowly for memory to testify reliably
  • Whether athlete's foot visits you, and what shoes your week actually involves

Questions worth asking

  • Can we test this before treating it — and will the culture name the organism?
  • Given what grows: topical, oral, or neither — and why that one for my nails?
  • What does success look like at month six, and where exactly should I look for it?
  • Do I need any blood tests before or during the oral course?
  • How do I keep from re-infecting a cured nail — and what do I do about my shoes?
  • If this course fails, what's the plan — re-test, switch, combine, or contain?

Cost and access. The economics are backwards from expectation: the strongest treatment is nearly the cheapest. Generic terbinafine costs pocket change in most systems; the clipping test is inexpensive and often the best-value item on the page; podiatry ranges from covered (high-risk feet) to modest self-pay. The expensive tiers are the branded topicals — hundreds per course in unfunded markets, though generics and regional pharmacy options soften this — and the laser clinics, where four figures buys the thinnest evidence on the page. Budget rule of thumb: money flows to tests and tablets before devices, and the order matters.

Two sentences move this appointment forward. 'Can we test it before treating it' marks you as the easiest kind of patient to help and spares everyone the awkwardness of a wasted course. And if a previous course failed, 'I'd like to re-test before repeating anything' is the professional's own instinct said out loud — wrong diagnoses, reinfections and resistant organisms all masquerade as failed treatment, and the clipping tells them apart.

Skincare alongside therapy

Supporting care here is ecosystem management: the fungus lives in shoes, socks, showers and skin as much as in the nail, and the habits below are what make any cure stick. None of it is glamorous; all of it out-earns its effort.

One principle runs the whole page: dry, cool, clean feet are hostile terrain. The fungus's entire strategy is warm trapped moisture — every habit that removes it is treatment, every habit that provides it is a subsidy.

While any course is running

The drug handles the nail; the routine handles everything the drug can't reach. Courses fail at the ecosystem level more often than the pharmacology level — reinfection from a neglected shoe is indistinguishable from treatment failure and far more common.

Do

  • Dry between the toes like it matters, because it does — after every shower, a towel or even a hairdryer on cool
  • Rotate at least two pairs of shoes so each dries fully between wears; antifungal powder for the gym pair
  • Change socks daily — moisture-wicking fibres for sweaty feet — and wash them hot
  • Photograph the nail base monthly; that advancing clear band is the entire scoreboard
  • Keep clippers and files for the infected nails separate, and disinfect after use

Avoid

  • Nail polish over a lacquer course unless your prescriber explicitly clears it — most topicals need the plate accessible
  • Barefoot circuits of pools, gym showers and hotel bathrooms mid-treatment — sandals are cheap armour
  • Judging anything at week six; the drug is working in nail you cannot see yet

What that looks like on a shelf: .

The standing prevention routine

Whether guarding a cure or containing an untreated nail, the same short list does the work. It's the routine version of the truth that most nail infections start as skin infections — police the skin and the nails mostly police themselves.

Do

  • Treat athlete's foot the week it appears, every time — the itch-to-cream interval is your actual risk number
  • Trim straight across, file the corners, and keep thick nails thinned before they press on neighbours
  • Air out footwear: alternate pairs, pull insoles at night, let winter boots actually dry
  • Sandals in every communal wet space, permanently — it's the cheapest intervention on this entire page

Avoid

  • Sharing clippers, files or shoes — fungus is a family heirloom nobody wants
  • Decades-old shoes 'too good to throw out' worn straight into a fresh cure
  • Salon pedicures with instruments you didn't watch come out of steriliser — or bring your own set

What that looks like on a shelf: .

The supporting shelf

Nail and foot product shelves arrive with the catalog's nail-care expansion; until then this section stays deliberately product-agnostic. The habits above need no shopping anyway — most of the prevention tier is a towel, a second pair of shoes, and promptness.

Take-home reference

Every therapy named above, in full. Look things up here; it is not meant to be read end to end.

Every therapy, explained

Reference, not reading — every therapy named anywhere above, described the way a clinician would describe it. Nobody reads this section end to end; open the one you were sent here for. Which one is right for you is the appointment's job, not this page's.

Over the counter

Available without a prescription. Each one opens with what to look for on a label, which is the part that stays true regardless of which brand is on the shelf that month.

Over-the-counter

Athlete's foot therapy

Clearing the reservoir

Generally compatible

The over-the-counter step that actually changes outcomes — treating the skin infection that feeds the nail one.

  • Terbinafine cream — The most fungicidal of the shelf options for dermatophyte skin infection — short courses, high clearance.
  • Azole creams (clotrimazole, miconazole) — The broad-spectrum alternatives; slightly longer courses, similar destination.

How it works

Most toenail infections are colonised from the foot's skin: the toe-webs and sole carry the dermatophyte population, and every recurrence starts there. Skin, unlike nail plate, is terrain topical antifungals win on — clearing it removes the source, protects the other nails, and guards whatever cure the higher tiers achieve.

What the evidence says well established

Topical terbinafine and azoles are established, effective treatments for athlete's foot; reservoir control is standard guidance in onychomycosis management to reduce reinfection after cure.

Typical course

One to four weeks depending on the agent, covering the webs and soles, not just the visibly peeling patch — then periodic re-treatment at the first sign of return, indefinitely.

Commonly discussed side effects

  • Occasional local irritation

Worth knowing

  • Treat the whole foot's terrain; the visible patch is the tip of the colony
  • Socks, shoes and shower floors are part of the ecosystem — the habits section below is half of this treatment

Pregnancy: Topical athlete's-foot treatment is generally regarded as compatible with pregnancy; confirming with a clinician is easy and worth it.

Why it sits where it does: It opens the ladder because it's the one shelf purchase with leverage over the actual outcome — every tier above works better, and lasts longer, over a cleared foot.

Over-the-counter

Urea softening and mechanical care

Thinning, trimming and comfort

Generally compatible

Bulk management — the unglamorous work that keeps thick nails comfortable and gives topical treatment a thinner wall to cross.

  • High-strength urea creams and ointments — Soften diseased plate over days to weeks so filing and trimming become possible and painless.
  • Dedicated files and clippers — Kept separate from anyone else's, and from your own healthy nails' tools — fungus commutes on shared steel.

Browse all urea products in our catalog →

How it works

Concentrated urea dissolves the bonds in keratin, softening thickened plate for reduction by file or clipper. Less bulk means less shoe pressure and less debris shelter — and for prescription lacquers, a measurably shorter diffusion path to the fungus. It kills nothing itself; it's civil engineering.

What the evidence says strong

Urea-based debridement is an established adjunct in nail disease management, improving comfort and topical drug penetration; mechanical reduction alongside pharmacological treatment is standard guideline practice.

Typical course

Urea applied daily to the affected plate (often under a plaster) for days to a couple of weeks, then careful filing; repeated in cycles as the nail regrows.

Commonly discussed side effects

  • Irritation of surrounding skin if slathered beyond the plate

Worth knowing

  • Diabetic or poorly-perfused feet skip the home version entirely — this exact task is what podiatry appointments are for
  • File in one direction, gently; enthusiasm here creates skin breaks the fungus's bacterial neighbours appreciate

Pregnancy: Topical urea and careful trimming carry no pregnancy concerns.

Why it sits where it does: It shares the shelf tier as the comfort-and-access work — valuable in itself for many, and force-multiplying for every topical above it.

Over-the-counter

The 'fungal nail' kits, honestly described

Perimeter antifungals

Generally compatible

The products the aisle actually sells under this condition's name — included here so their real job is on record.

  • Tolnaftate pens and solutions — A skin-monograph antifungal in nail-shaped packaging.
  • Undecylenic acid drops — Decades old, skin-level evidence, plate-level marketing.

How it works

Both are legitimate antifungals against dermatophytes on skin. Neither meaningfully penetrates nail plate, which is where this condition lives — so their honest roles are the skin at the nail's margins, the surrounding foot, and prevention on at-risk nails. The gap between that and the packaging's implication is the most expensive misunderstanding in this category.

What the evidence says limited

Monograph antifungals like tolnaftate and undecylenic acid have evidence for cutaneous fungal infection; evidence for curing established nail-plate infection is lacking, and no over-the-counter product holds a nail-cure indication.

Typical course

If used: daily to the nail margins and surrounding skin as perimeter defence, with expectations set to 'containment', not 'cure'.

Commonly discussed side effects

  • Rare irritation
  • The opportunity cost of months spent expecting more than containment

Worth knowing

  • A year of these on an established infection is the most common story in this condition — and the most avoidable
  • Money aimed at cure does better at the prescription tier; money aimed at prevention does fine here

Pregnancy: Topical use is low-concern; the honest question is whether to bother, given treatment usually defers to after pregnancy anyway.

Why it sits where it does: It sits on the shelf tier because it's what the shelf contains — described at its real size so the pathway's escalation logic makes sense.

What changed recently: The shelf itself has barely moved in decades — the meaningful recent movement is adjacent to it: prescription topicals designed specifically to penetrate nail plate (efinaconazole, tavaborole) arrived in the mid-2010s and remain the newest real chemistry, and in some countries amorolfine lacquer sits at pharmacy counters rather than behind full prescriptions, blurring the ceiling regionally. Worth asking a pharmacist what your country's counter actually carries.

Prescriptions and procedures

About the brand names below. Generic names carry this page: terbinafine, itraconazole and ciclopirox are dispensed generically nearly everywhere, and the branded newcomers matter mainly in markets where they're funded. Two label-reading notes specific to this condition: the pharmacy's 'fungal nail' section mixes true drug products with cosmetic 'nail renewal' kits that legally promise appearance, not cure — the active-ingredient line is the sorting tool; and the same antifungal name can appear as a cream for skin and a lacquer for nails at different strengths for different jobs. Where a region is missing in a brands section, that reflects what we could verify rather than proof of absence.

Prescription topical

Prescription nail topicals

Plate-penetrating antifungals

Individualized — ask a clinician

The topicals actually engineered for this problem — molecules and vehicles designed to cross the plate, prescribed for infections caught early and limited.

  • Efinaconazole solution — The best-performing of the modern topicals in trials; daily application through a full regrowth cycle.
  • Tavaborole solution — A different chemistry built for plate penetration; similar daily, long-haul use.
  • Ciclopirox 8% lacquer — The older option — weekly build-up, weekly removal, modest cure rates.
  • Amorolfine 5% lacquer — In the UK and elsewhere, available at pharmacy counters — weekly application for nine to twelve months.

What it's called at the pharmacy

Generic names Efinaconazole solution · Tavaborole solution · Ciclopirox 8% lacquer · Amorolfine 5% lacquer

Sold as

United States
  • Jublia (efinaconazole) and Kerydin (tavaborole) — prescription-only; ciclopirox lacquer as the generic elder
UK
  • Amorolfine lacquer (e.g. Curanail) available through pharmacists for limited infection — the NHS's own suggested route for mild distal disease

Regional availability genuinely differs here — the same molecule can be prescription-only in one country and a pharmacist conversation in another. The constant everywhere: these are commitments measured in months of daily or weekly application.

How it works

Purpose-built penetration — solvent systems and molecules chosen to diffuse through keratin and reach the nail bed at fungicidal concentrations. It works best where the journey is short: early, edge-first, limited-area infection with the nail base untouched. Cure rates are honest rather than heroic — meaningful for the right nails, clearly below the oral tier for established disease.

What the evidence says strong

Efinaconazole and tavaborole carry randomised-trial evidence and regulatory approval for onychomycosis; the Cochrane review of topical and device treatments supports efficacy over placebo while confirming lower cure rates than oral therapy. Guidelines position topicals for early, limited disease or where orals are unsuitable.

Typical course

Daily (solutions) or weekly (lacquers) through an entire regrowth cycle — nine to twelve months for toenails, judged by clear nail advancing from the base.

Commonly discussed side effects

  • Local irritation and redness around the nail
  • The adherence toll of a year-long daily ritual, which trial dropout rates quietly document

Monitoring

Progress reviewed by the growth line: new nail emerging clear means it's working, whatever the damaged tip still looks like.

Worth knowing

  • Debridement and urea thinning first is not optional garnish — penetration through full-thickness diseased plate is exactly what these struggle with
  • The foot reservoir stays treated throughout, or the cure meets its reinfection on the way out

Pregnancy: Usually simply deferred — the condition's pace makes waiting the standard and comfortable answer.

Why it sits where it does: It is the first prescription rung because it cures without systemic exposure — the right trade for early and limited infection, and for anyone whose medication list or preference rules the tablets out.

Prescription oral

Oral terbinafine

First-line systemic treatment

Avoid in pregnancy

The evidence-crowned centrepiece of nail fungus treatment — a daily tablet that reaches the fungus through the bloodstream, from the nail bed up.

What it's called at the pharmacy

Generic name Oral terbinafine

Sold as

Widely
  • Generic terbinafine everywhere; the originator name (Lamisil) survives mostly in memory and marketing

Cheap, generic and unglamorous — the strongest treatment on this page is also one of the least expensive.

How it works

Systemic delivery solves the plate problem from below: the drug arrives via the nail bed and matrix, incorporating into new nail as it forms, so the fungus's fortress is rebuilt as hostile territory. A twelve-week toenail course keeps working long after the last tablet, because the drug persists in the plate while the nail grows out.

What the evidence says well established

The Cochrane review found high-quality evidence that oral terbinafine achieves mycological and clinical cure versus placebo, and that it probably outperforms the azoles — the basis of its guideline first-line status. Absolute cure rates are honest: most treated nails improve, many clear fully, and a meaningful minority need a second act.

Typical course

Daily for six weeks (fingernails) or twelve weeks (toenails) — then months of watching clear nail advance while doing nothing further.

Commonly discussed side effects

  • Taste disturbance — occasionally profound and lingering, the side effect people actually quit over
  • Stomach upset, rash
  • Rare but real liver injury — the reason for the pre-course conversation and any monitoring your clinician orders

Monitoring

A medication and liver history before starting, with baseline or interval blood tests at clinician discretion. The famous reputation exceeds the actual risk profile for most healthy adults — but the check exists because 'most' isn't 'all'.

Worth knowing

  • Confirmation first is doctrine here: a systemic course aimed at an unconfirmed nail is the exact scenario the clipping test exists to prevent
  • Finish the course; the nail will look unchanged at week twelve, and that means nothing — the verdict lives at the growth line months later

Pregnancy: Deferred in pregnancy and nursing as standard — the condition waits graciously.

Why it sits where it does: It anchors the oral rung because the evidence anchors it there: the best cure rates on the page, generic pricing, and a finite course — the honest default for established disease in anyone cleared to take it.

Prescription oral

Oral azoles and the second line

Itraconazole and alternatives

Avoid in pregnancy

The systemic bench — for organisms terbinafine suits less, for interaction-driven substitutions, and for second attempts.

  • Itraconazole — The standard alternative — often pulse-dosed a week per month; carries a genuinely long drug-interaction list.
  • Fluconazole (off-label in some regions) — A weekly-dose option used where the first two don't fit.

What it's called at the pharmacy

Generic names Itraconazole · Fluconazole (off-label in some regions)

Sold as

Widely
  • Generic itraconazole and fluconazole are near-universal; pulse regimens vary by country and clinician

Which azole, which regimen, and whether at all is decided against your medication list — this is the tier where the pharmacist's interaction screen earns its keep.

How it works

Same strategy as terbinafine — systemic delivery through the nail bed — with different fungal coverage: azoles reach the yeasts and moulds that occasionally cause nail infection and that terbinafine covers less well, which is one more argument for the culture that names the organism.

What the evidence says strong

The Cochrane review supports azole efficacy against placebo for toenail onychomycosis, with terbinafine probably superior for the common dermatophytes — reserving azoles for non-dermatophyte organisms, intolerance, or interaction-driven choices.

Typical course

Continuous or pulsed over two to three months for toenails, per the chosen regimen — the same long grow-out judgement afterwards.

Commonly discussed side effects

  • Stomach upset, headache
  • Interaction potential is the headline: itraconazole shares metabolism with a long list of common drugs
  • Liver considerations as with the whole oral class

Monitoring

Medication reconciliation before, liver awareness during — the screening conversation is the safety feature.

Worth knowing

  • This is the rung where the lab culture pays off directly: matching drug to organism is what second-line means
  • Heart failure history matters for itraconazole specifically — say it even if unasked

Pregnancy: Deferred in pregnancy; itraconazole additionally carries pre-conception timing considerations worth raising if pregnancy is planned.

Why it sits where it does: It backs up the oral rung as the tailored option — chosen by organism, interaction list or prior failure rather than by default.

Procedure

Professional debridement and nail removal

Podiatry and minor procedures

Individualized — ask a clinician

The mechanical tier — from routine professional thinning to retiring a destroyed nail altogether.

  • Podiatric debridement — Skilled thinning and reduction of thick plates — comfort now, better topical penetration throughout.
  • Chemical or surgical nail removal — For the worst single plates: removing the fortress entirely so treatment reaches the bed, or ending a painful nail's career.

What it's called at the pharmacy

Generic names Podiatric debridement · Chemical or surgical nail removal

Sold as

Widely
  • Podiatry-delivered; availability and funding vary, with diabetic foot care the best-covered route in most systems

For diabetic and poorly-perfused feet this tier isn't an escalation — it's the standing baseline, and often the part a health system funds most readily.

How it works

Steel and skill where chemistry stalls: reducing infected bulk removes the debris mass topicals can't cross, relieves pressure pain immediately, and — in full removal for the worst cases — takes the plate out of the equation so antifungals treat an open nail bed directly while a fresh plate regrows.

What the evidence says strong

Debridement as an adjunct to antifungal therapy is standard guideline practice, improving symptoms and topical efficacy; removal of severely dystrophic nails is an established option for refractory or painful disease.

Typical course

Debridement in repeated sessions as the nail regrows; removal, where chosen, once — with the regrowth months managed like any other course on this page.

Commonly discussed side effects

  • Post-removal soreness and an adjustment period
  • Regrown nails after removal aren't always cosmetically perfect — worth hearing before, not after

Worth knowing

  • Removal without antifungal follow-through invites the same tenant into the new build
  • Home bathroom surgery on thick nails is how this condition generates its infections — the professional version exists for reasons

Pregnancy: Debridement is unproblematic; elective removal generally waits, with everything else here.

Why it sits where it does: It sits with the procedures as the force multiplier and the last resort in one — routine care for high-risk feet, adjunct for topical courses, and the definitive answer for a plate past saving.

Procedure

Laser and light devices

Device treatments, at their actual evidence size

Individualized — ask a clinician

The heavily marketed tier — included so the gap between its advertising and its regulatory clearance is on the record before anyone pays cash for it.

What it's called at the pharmacy

Generic name Laser and light devices

Sold as

Widely
  • Various platforms marketed through podiatry and cosmetic clinics, typically cash-pay, typically multi-session

The device clearances that exist are for temporary cosmetic improvement — clearer-looking nail — which is a categorically different claim from the mycological cure the tablets are judged on. Clinics don't always volunteer that distinction; this card does.

How it works

Laser energy heats the nail unit with the aim of damaging fungal organisms in place. Plausible physics, inconvenient evidence: trials are small, methods vary, and demonstrated cure rates lag well behind the oral tier — which is why the honest framing is cosmetic adjunct with an evidence file still being written, not drug-free equivalent.

What the evidence says limited

The Cochrane review of topical and device-based treatments found the evidence for lasers weak and inconsistent for achieving cure; regulatory clearances for these devices target temporary cosmetic improvement rather than mycological cure.

Typical course

Multiple sessions weeks apart, cash-priced, often alongside topicals — with success judged, as ever, at the growth line months later.

Commonly discussed side effects

  • Heat discomfort during sessions
  • The main documented risk is financial: four figures against an outcome the evidence can't yet promise

Worth knowing

  • Ask any laser clinic two questions: cure rate by culture at twelve months, and what happens if it fails — the quality of the answers is the consultation
  • A device pitched as 'avoiding the toxic tablets' is marketing against a safety profile most patients tolerate uneventfully — weigh the actual numbers on both sides

Pregnancy: Elective device sessions wait out pregnancy without controversy.

Why it sits where it does: It closes the map not as the strongest option but as the most oversold one — positioned last so the tiers with cure rates get the first look at your patience and your money.

On the horizon

Pipeline information current as of 2026-08-11

Only treatments in phase 3 or later, or recently reaching the market, for onychomycosis specifically.

This changes nothing about what to do now. Nothing below changes what to do now — and this field's newest approved chemistry is already a decade old, which says something useful about how to weigh clinic marketing against formularies.

Recently arrived

No major new approval in a decade (2026). The last genuinely new arrivals were the plate-penetrating topicals efinaconazole and tavaborole in the mid-2010s. Since then the treatment map has been stable: cheap generic orals with the best cure rates, purpose-built topicals for limited disease, and a device tier whose marketing has outpaced its evidence. Stability isn't stagnation — it means the standard answers are well-tested ones.

In late-stage development

Applying the phase-3 bar leaves a short honest list: antifungal candidates (including fosravuconazole, used in Japan) circle the space, device trials continue generating small studies, and formulation work keeps trying to get more drug through keratin. None of it yet threatens the current hierarchy — orals for cure rates, modern topicals for early disease. The claim to treat most skeptically remains the laser clinic's; the evidence file there is still the thinnest per dollar charged. Re-reviewed on the site's regular cycle.

Common questions

How do I know if my thick yellow nail is actually fungus?

You mostly can't by looking — and neither, honestly, can clinicians, which is why the test exists. Somewhere between a third and half of fungal-looking nails turn out to be psoriasis, footwear trauma, ageing changes or something else entirely, and every one of those ignores antifungal treatment completely. The test is as easy as medicine gets: clippings and debris sent for microscopy and culture, usually via a GP. It's the cheapest item on this whole page and the only one that converts everything after it from gambling to planning.

Why won't the pharmacy nail products cure it? They're right there in the fungal nail section.

Because the section is named after the problem, not the solution. The antifungals in those kits — tolnaftate, undecylenic acid — are genuinely effective on skin, but the nail plate is a dense keratin shield they can't meaningfully cross, and no over-the-counter product anywhere holds an approved nail-cure indication. Read the small print and you'll find careful phrasing about 'improving nail appearance' or treating the fungus 'around' the nail. Their honest jobs are the surrounding skin and prevention; the products with actual cure rates start at the prescription counter.

Are the antifungal tablets as dangerous as the internet says?

Their reputation runs a couple of decades behind their data. Terbinafine's serious liver risk is real but rare, and it's exactly why the pre-course conversation covers your liver history and medications, with blood tests at your clinician's discretion — the screening is the safety system working, not a warning sign. The side effect people actually quit over is more mundane: taste disturbance, which usually resolves after stopping but can be genuinely unpleasant. Weigh it against the alternative honestly — the tablets are a twelve-week course with the best cure rates on the page; the 'safe' route is often a year of daily lacquer at lower odds.

I finished the treatment months ago and the nail still looks bad. Did it fail?

Quite possibly not — look at the right end of the nail. Treatment doesn't repair damaged plate; it protects new growth, so the wrecked part you're staring at was always going to look wrecked until it grows off the end and gets clipped away. The question that matters: is the nail emerging at the base clear and normal? If yes, you're watching success in slow motion — toenails need nine to eighteen months to fully replace themselves. If the base is growing out infected too, that's a genuine failure signal, and it earns a re-test before any second course.

Do those laser treatments for nail fungus work?

At the price of the claim being made, no — not on current evidence. The Cochrane review of device treatments found the trial base small and inconsistent, and the regulatory clearances these devices hold are for temporary cosmetic improvement, a much humbler claim than the cure rates the tablets are judged against. That gap between clearance and clinic marketing is where your four figures go. If a clinic can show you culture-confirmed cure rates at twelve months and a plan for failure, listen; if the pitch is 'avoid the toxic pills', you're hearing marketing aimed at a fear the data doesn't support.

How did I even get this — and can I give it to my family?

Almost certainly from your own feet: athlete's foot is the usual source, and the nail infection is its slow-motion sequel — warm damp shoes, communal showers, pool decks and years of small nail traumas write most origin stories. Transmission to others is possible but lazy; the fungus spreads via shed skin and shared surfaces rather than casual contact. The practical courtesies: no shared towels, clippers or shoes, sandals in the family bathroom if your feet are actively peeling, and treat your athlete's foot promptly — that last one protects your household and your other nine nails simultaneously.

Is it worth treating at all? It doesn't hurt.

That's a legitimate question with a personal answer. Reasons to treat: it never resolves on its own, it slowly recruits neighbouring nails, thickened plates eventually do hurt in shoes, it's a standing reservoir for athlete's foot, and for anyone with diabetes or circulation trouble the calculus isn't optional — thick nails are a wound risk. Reasons some skip it: slow-growing elderly nails, medication conflicts, or simple indifference to how a toenail looks. What matters is choosing rather than drifting — 'contained, trimmed and monitored' is a real strategy, while 'ignored until it spreads' is just the expensive version of deciding later.

The other 133 questions

Everything that doesn’t fit on a therapy ladder — side effects, timelines, pregnancy, cost, the things people get told that aren’t true. Here are the ones asked most.

All 133 questions about nail fungus

Sources and further reading

The staging, escalation points, and therapy descriptions on this page are anchored to published clinical guidelines rather than editorial judgment.

What this page is built on

Everything on this page traces back to the sources below. Onychomycosis is well-served by evidence at the top tier — a dedicated national guideline and two Cochrane reviews — which makes the gap between that evidence and the retail marketing all the more visible.

Clinical guidelines and systematic reviews

The BAD guideline is the management framework; the Cochrane pair adjudicates the oral and topical/device tiers respectively.

Patient information

Written to be read.

Take the charts with you

Print exactly the piece you need. Each chart is one landscape page — no prose, no controls, sized to pin up or hand to someone — and the full document is the whole pathway as it reads on screen. Every printout carries the date, the source, and a line making clear it is not a diagnosis.

Printing happens in your browser. Your answers stay private — saved on this device, and to your free account when you're signed in.

No product is sold on this page, and no referral earns us anything. This layer of the site carries no advertising, no sponsorships, and no telehealth commissions — where the honest answer is "see a clinician," there is nothing here to sell.

Education, not medical advice. This page describes how nail fungus is treated in general; it diagnoses nothing and recommends no therapy to anyone. Read the full disclaimer.